Histogen Performance
| HSTODelisted Stock | USD 0.03 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Histogen are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Histogen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Histogen |
Histogen Relative Risk vs. Return Landscape
If you would invest 2.70 in Histogen on November 8, 2025 and sell it today you would earn a total of 0.00 from holding Histogen or generate 0.0% return on investment over 90 days. Histogen is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Histogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Histogen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Histogen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Histogen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Histogen is not yet fully synchronised with the market data | |
| Histogen has some characteristics of a very speculative penny stock | |
| Histogen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19 K. Net Loss for the year was (12.38 M) with loss before overhead, payroll, taxes, and interest of (3.26 M). | |
| Histogen currently holds about 12.6 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Histogen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Histogen Stock often depends not only on the future outlook of the current and potential Histogen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Histogen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.2 M | |
| Cash And Short Term Investments | 12.5 M |
Histogen Fundamentals Growth
Histogen Stock prices reflect investors' perceptions of the future prospects and financial health of Histogen, and Histogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Histogen Stock performance.
| Return On Equity | -1.2 | |||
| Return On Asset | -0.54 | |||
| Operating Margin | (705.00) % | |||
| Current Valuation | (4.46 M) | |||
| Shares Outstanding | 4.27 M | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 4.50 X | |||
| Revenue | 19 K | |||
| EBITDA | (11.92 M) | |||
| Cash And Equivalents | 12.6 M | |||
| Cash Per Share | 5.04 X | |||
| Total Debt | 4.63 M | |||
| Debt To Equity | 0.31 % | |||
| Book Value Per Share | 1.27 X | |||
| Cash Flow From Operations | (10.07 M) | |||
| Earnings Per Share | (2.81) X | |||
| Total Asset | 19.07 M | |||
| Retained Earnings | (88.27 M) | |||
About Histogen Performance
By examining Histogen's fundamental ratios, stakeholders can obtain critical insights into Histogen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Histogen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. Histogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.Things to note about Histogen performance evaluation
Checking the ongoing alerts about Histogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Histogen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Histogen is not yet fully synchronised with the market data | |
| Histogen has some characteristics of a very speculative penny stock | |
| Histogen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19 K. Net Loss for the year was (12.38 M) with loss before overhead, payroll, taxes, and interest of (3.26 M). | |
| Histogen currently holds about 12.6 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Histogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Histogen's stock is overvalued or undervalued compared to its peers.
- Examining Histogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Histogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Histogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Histogen's stock. These opinions can provide insight into Histogen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |